MYC and pancreatic neoplasm: While the use of direct and indirect targeting of MYC in pancreatic cancer is under development53, targeting SE-regulated gene networks such as those like MYC with TPL can lead to the elucidation of novel vulnerabilities, which may be eventually targeted using combinatorial therapeutic strategies.